Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 465081Generated: October 25, 2026

Triethylamine → 11-(2-(2-((Diethylamino)methyl)-1-piperidinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one

https://huagongshe.com/reaction/465081

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamineHCID 8471—
ReactantEthyl chloroformateHCID 10928—
ReactantSodium HydroxideHCID 14798—
Reactant5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oneHCID 70169—
SolventTetrahydrofuranHCID 8028—
Product11-(2-(2-((Diethylamino)methyl)-1-piperidinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oneHCID 10786729.9%

Reaction Conditions

Temperature0 °C

Reaction Steps

Ethyl chlorocarbonate (11.0 g, 0.101 mol) is added dropwise, at 0° C., to a suspension of 2-[(diethylamino)methyl]-1-piperidino acetic acid (22.83 g, 0.1 mol) in dry tetrahydrofuran (200 ml). Then, 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one (21.12 g, 0.1 mol) and triethylamine (20.24 g, 0.2 mol) are added to the resulting suspension which is then stirred for a further hour at 0° C. and then for 4 hours at ambient temperature. The mixture is poured into 2N sodium hydroxide solution (1.6 liters), extracted exhaustively with dichloromethane, the organic phase concentrated to dryness and the residue purified by recrystallization from ethanol and from methanol. Colorless crystals (6.3 g) are obtained, mp. 226°-228° C., which were shown by thin layer chromatography, mixed melting point and IR spectrum to be identical to a sample prepared according to Example 34.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04550107
Source datasetuspto-grants-1985_10
ORD IDord-901753c25af7418f9c10fcb008b79f6c
Source noteuspto-grants-1985_10